Literature DB >> 8259143

Hemophilia A.

L W Hoyer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8259143     DOI： 10.1056/NEJM199401063300108

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

Review 1.  Management of hemophilia in developing countries.

Authors:  R Kashyap; V P Choudhry
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

2.  Presentation of severe haemophilia--a role for accident and emergency doctors?

Authors:  H L Minhas; P L Giangrande
Journal:  Emerg Med J       Date:  2001-07       Impact factor: 2.740

3.  HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.

Authors:  R A Ettinger; E A James; W W Kwok; A R Thompson; K P Pratt
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

4.  Determinants of drug costs in hopitalised patients with haemophilia: impact of recombinant activated factor VII.

Authors:  Jean Philippe Galanaud; Nathalie Pelletier-Fleury; Hélène Logerot-Lebrun; Thierry Lambert
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Antihemophilic factor [recombinant], formulated with sucrose.

Authors: 
Journal:  P T       Date:  2010-09

Review 6.  Endothelial progenitor cell-based therapy for hemophilia A.

Authors:  Hideto Matsui
Journal:  Int J Hematol       Date:  2012-02       Impact factor: 2.490

7.  Need for Prophylactic Treatment in Adult Haemophilia A Patients.

Authors:  Berthold Siegmund; Heinrich Richter; Hartmut Pollmann
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

Review 8.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

9.  Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.

Authors:  M Neale Weitzmann; Susanne Roser-Page; Tatyana Vikulina; Daiana Weiss; Li Hao; W Hunter Baldwin; Kanglun Yu; Natalia Del Mazo Arbona; Meghan E McGee-Lawrence; Shannon L Meeks; Christine L Kempton
Journal:  Blood Adv       Date:  2019-02-12

10.  Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII gene.

Authors:  J M Staber; M J Pollpeter; C-G Anderson; M Burrascano; A L Cooney; P L Sinn; D T Rutkowski; W C Raschke; P B McCray
Journal:  Gene Ther       Date:  2017-09-14       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.